13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 18 holding rows worth $95,990,877.
- Accession
- 0001193125-26-055035
- Filer
- CIK 1822947
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 20 entries on the cover page, a total value of $95,990,877 stated on the cover page (in dollars after the unit check, H1), rows summing to $95,990,877 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,200,000 | $11,664,000 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 70,000 | $9,439,850 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 168,029 | $7,779,743 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,100,000 | $7,590,000 | dollars as filed | call |
| ATAIBECKLEY INC | N0731H103 | Equity | 1,713,105 | $7,006,599 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,500,000 | $6,975,000 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,655,500 | $6,655,110 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 250,000 | $6,203,750 | dollars as filed | put |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 19,882 | $5,860,021 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 195,000 | $4,838,925 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 200,000 | $4,786,000 | dollars as filed | call |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 397,895 | $3,004,107 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,785,000 | $2,909,550 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 500,000 | $2,750,000 | dollars as filed | call |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 457,132 | $2,514,226 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 413,625 | $2,332,845 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 817,939 | $1,979,412 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 249,339 | $1,701,739 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-055035 | this filing | 2026-02-17 | acceptance time not in the bulk data set |